Neurology, by Application to Account Largest Embolization Plugs Market Share during 2025-2031

According to our new research study on "Embolization Plugs Market Forecast to 2031 - Global Analysis - by Application, End User, and Geography," the market was valued at US$ 315.24 million in 2024 to US$ 564.45 million by 2031; the market is expected to register a CAGR of 8.8% during 2025-2031. The embolization plugs market growth is attributed to the rising prevalence of vascular diseases, growing demand for minimally invasive procedures, and technological advancements in device design drive the adoption of embolization plugs. The integration of hybrid materials and smart technologies is projected to bring new embolization plugs market trends in the coming years.

The increasing preference for minimally invasive procedures for vascular interventions is expected to drive the embolization plugs market. These procedures have improved patient safety, allows faster recovery, and have fewer complications as compared to conventional open surgeries. Embolization plugs are at the core of these methods as they block the abnormal blood flow while the rest of the tissues are kept intact. Their use has increased quite rapidly due to the worldwide trend towards outpatient care and cost-saving measures by healthcare systems, especially in cases of vascular anomalies, tumors, and bleeding disorders.

For instance, the increased use of vascular plugs in uterine artery embolization (UAE) for symptomatic uterine fibroids, which are benign tumors that hamper women's reproductive health. The National Institutes of Health (NIH) states that uterine fibroids affect 70-80% of women by the age of 50. As a result, in the US approximately 26 million women of childbearing age are affected and this leads to heavy menstrual bleeding, pelvic pain, and in rare cases, infertility. This procedure is minimally invasive and catheterization through the femoral artery leads to reduced hospital stays which is in line with the global trend of less burdensome treatments.

In cancer treatment, embolization plugs are a must-have for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) which is the leading cause of liver cancer. The WHO reported 905,677 new cases of HCC and 830,180 deaths worldwide in 2020 and the majority of them were in Asia and Africa due to hepatitis B and cirrhosis. TACE achieves local chemotherapy delivery with the use of plugs to block the vessel, thus facilitating drug retention and tumor necrosis rates reaching 40-70% according to the studies linked to the WHO. This method doubles the median survival time from 8 months with only supportive care to 20 months, a clear indication that it extends the patient's life considerably.

Another important application of embolization plugs is the treatment of abdominal aortic aneurysm (AAA), the pathological dilations of vessels that can rupture. According to CDC data, AAA affects 1.1% of men aged 65-74 in the US while the worldwide prevalence goes from 4-8% in elderly men as per the European Society for Vascular Surgery guidelines. Endovascular aneurysm repair (EVAR) uses plugs to close the endoleaks thus decreasing the chance of rupture quite a lot compared to open surgery and the perioperative mortality rate is reduced to less than 2%. Moreover, embolization plugs also help in the treatment of complications such as acute limb ischemia by achieving selective occlusion, thus saving 70% of the intervention cases from limb amputation. Therefore, rising inclination towards minimally invasive interventions, the embolization plugs can transform the vascular care, offering hope to millions afflicted by widespread conditions.

Based on application, the embolization plugs market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. The neurology segment held a significant embolization plugs market share in 2024. Embolization plugs are progressively being utilized in neurology to mend intricate cerebrovascular scenarios such as cerebral aneurysms, arteriovenous malformations (AVMs), and dural arteriovenous fistulas. Their accurate delivery and control make them a perfect match for the sensitive neurovascular anatomy. For example, the Amplatzer Vascular Plug can be guided through the highly twisted cerebral vessels to isolate aneurysm sacs, thus inducing thrombosis with little or no vessel trauma. The growth in this segment is mainly due to the increased incidence of neurovascular diseases, the improved neuroimaging techniques, and the shift to minimally invasive neurointerventional therapies. Moreover, because of technological innovations, embolization plugs are being designed for increased biocompatibility, better radiopacity, and accurate deployment through micro-catheters, which is a great advantage in the narrow and delicate vessels of the brain. These plugs provide the means for controlled occlusion, thus lessening the possibility of migration in high-flow cerebral lesions.

Medtronic Plc, Terumo Corp., INVAMED, Abbott Laboratories, Merit Medical Systems Inc, Lifetech Scientific Corp, Shape Memory Medical, and ArtVentive Medical Group are among the leading companies operating in the global embolization plugs market.

Companies operating in the embolization plugs market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the embolization plugs market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall embolization plugs market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com